Literature DB >> 20393789

Involvement of Th17 and Th1 effector responses in patients with Hepatitis B.

Yufu Ye1, Xiaojun Xie, Jiwei Yu, Lin Zhou, Haiyang Xie, Guoping Jiang, Xiaobo Yu, Wenjin Zhang, Jian Wu, Shusen Zheng.   

Abstract

BACKGROUND: Local production of cytokines within the liver may play a pivotal role in the regulation of pathophysiological processes during inflammation. CD4+ T cells are regarded as the most prolific cytokine producers. The purpose of this study was to quantify intrahepatic expression of Th1, Th2, Th17, and Treg-associated cytokines or transcription factors in patients with acute hepatitis B or chronic hepatitis B (CHB) and to analyze their relative roles in the promotion and regulation of hepatitis B virus (HBV)-associated liver diseases.
METHODS: Distribution and expression of IL-17, IFN-gamma, IL-4, Foxp3, and other cytokines in liver tissues were detected by immunohistochemistry and real-time quantitative PCR. Patients with hepatitis B were compared with patients with chronic hepatitis C, primary biliary cirrhosis, alcoholic liver cirrhosis, and healthy controls.
RESULTS: The frequencies of intrahepatic IL-17 and IFN-gamma-producing cells in patients with HBV-associated liver dysfunction were much higher than that of IL-4 and Foxp3-positive cells. The level of the IL-17/IFN-gamma-positive cell ratio of patients with Child-Pugh class C (1.57+/-0.09) was much higher than that of patients with Child-Pugh class B (1.00+/-.02) or A (0.93+/-0.05). There are more IL-17-producing cells than IFN-gamma-producing cells accumulating in the liver with severe hepatocellular damage. Liver IL-17-producing cell infiltration was positively associated with the grade of liver inflammation in CHB and positively correlated to intrahepatic IL-8 expression (r=0.801, p<0.01) or neutrophil infiltration (r=0.917, p<0.01).
CONCLUSIONS: These results suggest that the balance of effector CD4+ Th responses (Th17 and Th1 responses) and regulatory response is an important element of immune regulation. Inappropriate, excessive, and non-specific Th17 and Th1 effector responses may be involved in the pathogenesis of HBV-associated liver inflammation and hepatocellular damage. Th17 response, especially, may exacerbate the inflammatory processes leading to liver failure. IL-17-mediating liver neutrophil recruitment via induction of IL-8 may be one potential mechanism of liver injury in patients with hepatitis B. An improved understanding of the factors that influence the differentiation and function of these cell types in vivo will be of great importance to the future development of immune therapies in HBV-associated liver disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393789     DOI: 10.1007/s10875-010-9416-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 3.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 4.  Role of neutrophils in acute inflammatory liver injury.

Authors:  Hartmut Jaeschke; Tadashi Hasegawa
Journal:  Liver Int       Date:  2006-10       Impact factor: 5.828

5.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

6.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 8.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 9.  Interleukin-17.

Authors:  F Fossiez; J Banchereau; R Murray; C Van Kooten; P Garrone; S Lebecque
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

10.  Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.

Authors:  Feng Zhang; Li-Ming Wu; Lin Zhou; Qi-Xing Chen; Hai-Yang Xie; Xiao-Wen Feng; Shu-Sen Zheng
Journal:  Ann Surg Oncol       Date:  2008-10-02       Impact factor: 5.344

View more
  39 in total

1.  Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.

Authors:  Li-Yuan Wang; Qing-Hua Meng; Zhi-Qiang Zou; Yu-Chen Fan; Jie Han; Zhao-Xia Qi; Jian Ge; Ai-Ling Xu; Si-Kui Wang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

Review 2.  Gut microbiota modulate the immune effect against hepatitis B virus infection.

Authors:  D Xu; Y Huang; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-14       Impact factor: 3.267

3.  Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection.

Authors:  Yanping Gong; Chao Zhao; Peng Zhao; Meifang Wang; Guoqiang Zhou; Fu Han; Yanhong Cui; Jianping Qian; Hongxing Zhang; Huaimin Xiong; Jianhua Sheng; Tingwang Jiang
Journal:  Dig Dis Sci       Date:  2014-09-27       Impact factor: 3.199

Review 4.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

5.  Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.

Authors:  Meilan Cui; Ying Lv; Jianhua Lu; Wei Zhang; Yuanyuan Duan; Yan Huang; Lei Yang; Man Li; Wenxuan Liu; Dianwu Liu; Huimin Yan
Journal:  J Clin Lab Anal       Date:  2017-05-08       Impact factor: 2.352

Review 6.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

7.  Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure.

Authors:  Hee Yeon Kim; Joo Yeon Jhun; Mi-La Cho; Jong Young Choi; Jae Kyeong Byun; Eun-Kyung Kim; Seung Kew Yoon; Si Hyun Bae; Byung Ha Chung; Chul Woo Yang
Journal:  J Gastroenterol       Date:  2013-12-25       Impact factor: 7.527

8.  Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure.

Authors:  Lin Zhu; Tao Chen; Yulei Lu; Di Wu; Xiaoping Luo; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

9.  The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B.

Authors:  S Zhu; H Zhang; Y Dong; Z Xu; D Chen; L Wang; Y Gan; F Wang; Y Wang; X Xing; S Hu; Z Li; L Long; L Liu; Y Zhong
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

10.  Investigation on effects of the nourishing kidney and eliminating toxicity decoction on immunological imbalance of Th1, Th17 and Treg in HBV transgenic mice.

Authors:  Ya-Min Liu; Qiu-Ying Xu; Jun-Xian Chen; Song Chen; Hao-Jun Peng; Zheng-Lun Zeng; Zhi-Yu Feng; Qiang Shen
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.